CompanyNasdaqNew York, NY
Lucid Diagnostics Inc
Lucid Diagnostics develops the EsoGuard esophageal DNA test and EsoCheck cell collection device to detect esophageal precancer in patients with GERD.
8-KOct 22Latest SEC filing
Form DDec 6$22M sold
Sign in